Identification of a clinically homogenous subgroup of benign cortisol-secreting adrenocortical tumors characterized by alterations of the protein kinase A (PKA) subunits and high PKA activity

European Journal of Endocrinology

Volumn 158, Issue 6, 2008, Pages 829-839

  Vincent Dejean, C ^a,b   Cazabat, L ^a,b   Groussin, L ^a,b,c   Perlemoine, K ^a,b   Fumey, G ^a,b   Tissier, F ^a,b,d   Bertagna, X ^a,b,c,e   Bertherat, Jerome ^a,b,c,d,e  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d Hôpital Cochin ^*  (France)

^e COMETE INCA Rare Adrenal Cancer Network ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; MESSENGER RNA; PROTEIN PRKAR1A; PROTEIN PRKAR2B; REGULATOR PROTEIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT IIBETA; HYDROCORTISONE; PRKAR2B PROTEIN, HUMAN;

ADOLESCENT; ADRENAL CANCER; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CANCER; ADRENAL CORTEX TUMOR; ADULT; AGED; ARTICLE; CANCER RESEARCH; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORTISOL SECRETING ADRENAL CORTEX ADENOMA; CORTISOL SECRETING ADRENAL CORTEX TUMOR; CUSHING SYNDROME; FEMALE; GENE SEQUENCE; HUMAN; HUMAN TISSUE; HYDROCORTISONE RELEASE; IMMUNOHISTOCHEMISTRY; MALE; NONSECRETING ADRENAL CORTEX ADENOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; WESTERN BLOTTING; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; SECRETION;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADULT; AGED; BLOTTING, WESTERN; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIIBETA SUBUNIT; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; HUMANS; HYDROCORTISONE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 44949097324     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0819     Document Type: Article

References (35)

1. Libe R & Bertherat J. Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. European Journal of Endocrinology 2005 153 477-487.
2. Lania A, Mantovani G & Spada A. G protein mutations in endocrine diseases. European Journal of Endocrinology 2001 145 543-559.
3. Rosenberg D, Groussin L, Bertagna X & Bertherat J. cAMP pathway alterations from the cell surface to the nucleus in adrenocortical tumors. Endocrine Research 2002 28 765-775.
4. Beuschlein F, Fassnacht M, Klink A, Allolio B & Reincke M. ACTH-receptor expression, regulation and role in adrenocortial tumor formation. European Journal of Endocrinology 2001 144 199-206.
5. Groussin L, Jullian E, Perlemoine K, Louvel A, Leheup B, Luton JP, Bertagna X & Bertherat J. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. Journal of Clinical Endocrinology and Metabolism 2002 87 4324-4329.
6. Groussin L, Horvath A, Jullian E, Boikos S, Rene-Corail F, Lefebvre H, Cephise-Velayoudom FL, Vantyghem MC, Chanson P, Conte-Devolx B. Lucas M, Gentil A, Malchoff CD, Tissier F, Carney JA, Bertagna X, Stratakis CA & Bertherat J. A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds. Journal of Clinical Endocrinology and Metabolism 2006 91 1943-1949.
7. Swords FM, Baig A, Malchoff DM, Malchoff CD, Thorner MO, King PJ, Hunyady L & Clark AJ. Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity. Molecular Endocrinology 2002 16 2746-2753.
8. Libe R, Mantovani G, Bondioni S, Lania AG, Pedroni C, Beck-Peccoz P & Spada A. Mutational analysis of PRKAR1A and Gsα in sporadic adrenocortical tumors. Experimental and Clinical Endocrinology and Diabetes 2005 113 248-251.
9. Horvath A, Boikos S, Giatzakis C, Robinson-White A, Groussin L, Griffin KJ, Stein E, Levine E, Delimpasi G, Hsiao HP, Keil M, Heyerdahl S, Matyakhma L, Libe R, Fratticci A, Kirschner LS, Cramer K, Gaillard RC, Bertagna X, Carney JA, Bertherat J, Bossis I & Stratakis CA. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nature Genetics 2006 38 794-800.
10. Casey M, Vaughan CJ, He J, Hatcher CJ, Winter JM, Weremowicz S, Montgomery K, Kucherlapati R, Morton CC & Basson CT. Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. Journal of Clinical Investigation 2000 106 R31-R38.
11. Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA & Stratakis CA. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex. Human Molecular Genetics 2000 9 3037-3046.
12. Stratakis CA, Kirschner LS & Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. Journal of Clinical Endocrinology and Metabolism 2001 86 4041-4046.
13. Bertherat J, Groussin L, Sandrini F, Matyakhina L, Bei T, Stergiopoulos S, Papageorgiou T, Bourdeau I, Kirschner LS, Vincent-Dejean C, Perlemoine K, Gicquel C, Bertagna X & Stratakis CA. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Research 2003 63 5308-5319.
14. Corbin JD, Keely SL & Park CR. The distribution and dissociation of cyclic adenosine 3′: 5′-monophosphate-dependent protein kinases in adipose, cardiac, and other tissues. Journal of Biological Chemistry 1975 250 218-225.
15. Bossis I & Stratakis CA. Minireview: PRKAR1A: normal and abnormal functions. Endocrinology 2004 145 5452-5458.
16. Skalhegg BS & Tasken K. Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Frontiers in Bioscience 2000 5 D678-D693.
17. Cummings DE, Brandon EF, Planas JV, Motamed K, Idzerda RL & McKnight GS. Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A. Nature 1996 382 622-626.
18. Sandrini F, Matyakhina L, Sarlis NJ, Kirschner LS, Farmakidis C, Gimm O & Stratakis CA. Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer. Genes, Chromosomes and Cancer 2002 35 182-192.
19. Libe R, Fratticci A & Bertherat J. Adrenocortical cancer: pathophysiology and clinical management. Endocrine-Related Cancer 2007 14 13-28.
20. Libe R, Groussin L, Tissier F, Elie C, Rene-Corail F, Fratticci A, Jullian E, Beck-Peccoz P, Bertagna X, Gicquel C & Bertherat J. Somatic TP 53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity. Clinical Cancer Research 2007 13 844-850.
21. Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagnere AM, Rene-Corail F, jullian E, Gicquel C, Bertagna X, Vacher-Lavenu MC, Perret C & Bertherat J. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Research 2005 65 7622-7627.
22. Bertherat J, Groussin L & Bertagna X. Mechanisms of disease: adrenocortical tumors - molecular advances and clinical perspectives. Nature Clinical Practice. Endocrinology and Metabolism 2006 2 632-641.
23. Lacroix A, Ndiaye N, Tremblay J & Hamet P. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocrine Reviews 2001 22 75-110.
24. Groussin L, Perlemoine K, Contesse V, Lefebvre H, Tabarin A, Thiebiot P, Schlienger JL, Luton JP, Bertagna X & Bertherat J. The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors. Journal of Clinical Endocrinology and Metabolism 2002 87 1980-1985.
25. Groussin L, Kirschner LS, Vincent-Dejean C, Perlemoine K, Jullian E, Delemer B, Zacharieva S, Pignatelli D, Carney JA, Luton JP, Bertagna X, Stratakis CA & Bertherat J. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. American Journal of Human Genetics 2002 71 1433-1442.
26. Rosenberg D, Groussin L, Jullian E, Perlemoine K, Bertagna X & Bertherat J. Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues. Annals of the New York Academy of Sciences 2002 968 65-74.
27. Peri A, Luciani P, Conforti B, Baglioni-Pert S, Cioppi F, Crescioli C, Ferruzzi P, Gelmini S, Arnaldi G, Nesi G, Serio M, Mantero F & Mannelli M. Variable expression of the transcription factors cAMP response element- binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. Journal of Clinical Endocrinology and Metabolism 2001 86 5443-5449.
28. Rosenberg D, Groussin L, Jullian E, Perlemoine K, Medjane S, Louvel A, Bertagna X & Bertherat J. Transcription factor 3′,5′-cyclic adenosine 5′-monophosphate-responsive element-binding protein (CREB) is decreased during human adrenal cortex tumorigenesis and fetal development. Journal of Clinical Endocrinology and Metabolism 2003 88 3958-3965.
29. Bourdeau I, Matyakhina L, Stergiopoulos SG, Sandrini F, Boikos S & Stratakis CA. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 2006 91 3626-3632.
30. Lania AG, Mantovani G, Ferrero S, Pellegrini C, Bondioni S, Peverelli E, Braidotti P, Locatelli M, Zavanone ML, Ferrante E, Bosari S, Beck-Peccoz P & Spada A. Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein. Cancer Research 2004 64 9193-9198.
31. Mantovani G, Lania AG, Bondioni S, Peverelli E, Pedroni C, Ferrero S, Pellegrini C, Vicentini L, Arnaldi G, Bosari S, Beck-Peccoz P & Spada A. Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: relationship with cell proliferation. Experimental Cell Research 2008 314 123-130.
32. Amieux PS, Cummings DE, Motamed K, Brandon EP, Wailes LA, Le K, Idzerda RL & McKnight GS. Compensatory regulation of RIalpha protein levels in protein kinase A mutant mice. Journal of Biological Chemistry 1997 272 3993-3998.
33. Planas JV, Cummings DE, Idzerda RL & McKnight GS. Mutation of the RIIbeta subunit of protein kinase A differentially affects lipolysis but not gene induction in white adipose tissue. Journal of Biological Chemistry 1999 274 36281-36287.
34. Esapa CT & Harris PE. Mutation analysis of protein kinase A catalytic subunit in thyroid adenomas and pituitary tumours. European Journal of Endocrinology 1999 141 409-412.
35. McDaid HM, Cairns MT, Atkinson RJ, McAleer S, Harkin DP, Gilmore P & Johnston PG. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer. British Journal of Cancer 1999 79 933-939.